NCT07784348 Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
| NCT ID | NCT07784348 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-05-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET), followed by a randomized controlled trial of CET+BPT for young children with ADHD.
Eligibility Criteria
Inclusion Criteria: * principal ADHD diagnoses (via K-SADS); (b) parent BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range (\>90th percentile) based on age and sex; (c) teacher BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range based on age and sex Exclusion Criteria: * (a) gross neurological, sensory, or motor impairment; (b) history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (e.g., disruptive mood dysregulation, conduct, intermittent explosive, reactive attachment); (c) intellectual disability or WPPSI/WISC short-form FSIQ\<70; (d) conditions requiring acute intervention, e.g., active suicidality; and (e) non-English speaking child or parent.
Contact & Investigator
Michael Kofler, PhD
PRINCIPAL INVESTIGATOR
Florida State University
Frequently Asked Questions
Who can join the NCT07784348 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 8 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07784348 currently recruiting?
Yes, NCT07784348 is actively recruiting participants. Contact the research team at clc@psy.fsu.edu for enrollment information.
Where is the NCT07784348 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT07784348 clinical trial?
NCT07784348 is sponsored by Florida State University. The principal investigator is Michael Kofler, PhD at Florida State University. The trial plans to enroll 120 participants.